About Site
Affordable Medicines Facility - malaria
Board
Business Opportunities
Country Coordinating Mechanisms
Civil Society and the Private Sector
Donate
Donors
Employment
Friends of the Fund
High Level Independent Review Panel
Innovative Financing
Local Fund Agents
Monitoring and Evaluation
National Strategy Applications
Office of Inspector General
Partnership Forum
Performance
Performance Based Funding
Private Sector
Pharmaceutical Procurement and Supply Management
Regional Meetings
Saving Lives: Stories from the Fight
Technical Evaluation and Reference Group
Technical Review Panel
Transitional Funding Mechanism
An appeal mechanism has been established for applicants whose proposals are not approved for funding by the Board, providing them with the possibility of having this decision reconsidered by an Independent Appeals Panel.
The only grounds for an appeal are that the Technical Review Panel (TRP) has made a significant and obvious error regarding the information contained in the proposal not approved for funding. Applicants must demonstrate this error based on the proposal that was reviewed by the TRP, and no new information or new justification may be introduced in an Appeal.
Applicants who wish to appeal a decision of the Board must submit a notice of appeal ('Appeal Form') no later than 28 days from the date on which the applicant received written notice of the decision. The Secretariat sends an Appeal Form to all eligible. applicants.
The Appeal procedure comprises two stages:
An Independent Appeal Panel assesses the merits of the appeal and makes a recommendation to the Global Fund Board; and
The Global Fund Board makes a decision on the appeal.
The Appeal Panel is comprised of five experts:
An expert nominated by the Stop TB Partnership, Roll Back Malaria Partnership and UNAIDS, in close collaboration with WHO's HIV/AIDS, tuberculosis and malaria departments; and
Two current TRP members, provided that neither expert was the primary or secondary reviewer of the specific proposal under review by the Appeal Panel.
In Round 9, 26 components (including 2 cross-cutting HSS requests) were eligible for appeal; 9 applicants decided to submit an appeal; 2 applicants were successful. For more information, please see the Appeal Panel Report for Round 9 and First Wave Learning Wave of NSAs.